The role of environmental factors in primary biliary cirrhosis

Trends in Immunology

Volumn 30, Issue 8, 2009, Pages 415-420

  Selmi, Carlo ^a   Gershwin, M Eric ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

XENOBIOTIC AGENT;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CHOLESTASIS; CHOLESTATIC HEPATITIS; ENVIRONMENTAL FACTOR; FEMALE; GENETIC PREDISPOSITION; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; INFECTION; LIVER DISEASE; MALE; MOLECULAR MIMICRY; MONOZYGOTIC TWINS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; REVIEW; RISK FACTOR; SEX DIFFERENCE;

AUTOIMMUNE DISEASES; BILE DUCTS; ENVIRONMENT; FEMALE; HUMANS; INCIDENCE; INFECTION; LIVER CIRRHOSIS, BILIARY; MALE; PREVALENCE; XENOBIOTICS;

EID: 68149119166     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.05.006     Document Type: Review

References (76)

1. Shoenfeld Y., et al. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J. Autoimmun. 31 (2008) 325-330
2. Kaplan M.M., and Gershwin M.E. Primary biliary cirrhosis. N. Engl. J. Med. 353 (2005) 1261-1273
3. Selmi C., et al. The unfinished business of primary biliary cirrhosis. J. Hepatol. 49 (2008) 451-460
4. Abbas A.K., et al. Balancing autoaggressive and protective T cell responses. J. Autoimmun. 28 (2007) 59-61
5. Blank M., and Shoenfeld Y. B cell targeted therapy in autoimmunity. J. Autoimmun. 28 (2007) 62-68
6. Youinou P. B cell conducts the lymphocyte orchestra. J. Autoimmun. 28 (2007) 143-151
7. Selmi C., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127 (2004) 485-492
8. Rieger R., and Gershwin M.E. The X and why of xenobiotics in primary biliary cirrhosis. J. Autoimmun. 28 (2007) 76-84
9. Benson G.D., et al. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin. Dev. Immunol. 11 (2004) 129-133
10. Muratori L., et al. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin. Liver Dis. 12 (2008) 261-276
11. Mutimer D.J., et al. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology 10 (1989) 403-407
12. Tsuneyama K., et al. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Hepatology 22 (1995) 1440-1446
13. Reynoso-Paz S., et al. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology 31 (2000) 24-29
14. Tanaka A., et al. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis. Ann. N. Y. Acad. Sci. 1107 (2007) 259-270
15. Oertelt S., et al. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45 (2007) 659-665
16. Odin J.A., et al. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J. Clin. Invest. 108 (2001) 223-232
17. Lleo A., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 49 (2009) 871-879
18. Gershwin M.E., and Mackay I.R. The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology 47 (2008) 737-745
19. Invernizzi P., et al. Antinuclear antibodies in primary biliary cirrhosis. Semin. Liver Dis. 25 (2005) 298-310
20. Wesierska-Gadek J., et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 43 (2006) 1135-1144
21. Nakamura M., et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45 (2007) 118-127
22. Ishibashi H., et al. T cell immunity and primary biliary cirrhosis. Autoimmun. Rev. 2 (2003) 19-24
23. Shimoda S., et al. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J. Exp. Med. 181 (1995) 1835-1845
24. Kita H., et al. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J. Exp. Med. 195 (2002) 113-123
25. Sharma R., et al. Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice. J. Autoimmun. 29 (2007) 10-19
26. Lan R.Y., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43 (2006) 729-737
27. Abu-Mouch S., et al. Geographic clusters of primary biliary cirrhosis. Clin. Dev. Immunol. 10 (2003) 127-131
28. Selmi C., et al. Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin. Liver Dis. 25 (2005) 265-280
29. Arber S., et al. Patient characteristics and inequalities in doctors' diagnostic and management strategies relating to CHD: a video-simulation experiment. Soc. Sci. Med. 62 (2006) 103-115
30. Watson R.G., et al. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut 36 (1995) 927-930
31. Sood S., et al. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 127 (2004) 470-475
32. Kim W.R., et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 119 (2000) 1631-1636
33. Arbour L., et al. Characteristics of primary biliary cirrhosis in British Columbia's First Nations population. Can. J. Gastroenterol. 19 (2005) 305-310
34. Ala A., et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 43 (2006) 525-531
35. Invernizzi P., et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 48 (2008) 1906-1912
36. Invernizzi P., and Gershwin M.E. The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology 135 (2008) 1044-1047
37. Gershwin M.E., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42 (2005) 1194-1202
38. Parikh-Patel A., et al. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology 33 (2001) 16-21
39. Van de Water J., et al. Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology 33 (2001) 771-775
40. Tsuneyama K., et al. Scavenger cells with gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis. J. Hepatol. 35 (2001) 156-163
41. Shimoda S., et al. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 31 (2000) 1212-1216
42. Kaplan M.M. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am. J. Gastroenterol. 99 (2004) 2147-2149
43. Fujii K., et al. Degradation of 17beta-estradiol by a gram-negative bacterium isolated from activated sludge in a sewage treatment plant in Tokyo, Japan. Appl. Environ. Microbiol. 68 (2002) 2057-2060
44. Mattner J., et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3 (2008) 304-315
45. Ehlers M., and Ravetch J.V. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol. 28 (2007) 74-79
46. Agrawal S., and Kandimalla E.R. Modulation of toll-like receptor 9 responses through synthetic immunostimulatory motifs of DNA. Ann. N. Y. Acad. Sci. 1002 (2003) 30-42
47. Mao T.K., et al. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42 (2005) 802-808
48. Selmi C., et al. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 127 (2004) 493-501
49. Selmi C., and Gershwin M.E. The retroviral myth of primary biliary cirrhosis: is this (finally) the end of the story?. J. Hepatol. 51 (2009) 412-413
50. Long S.A., et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J. Immunol. 167 (2001) 2956-2963
51. McFadden J.P., et al. Does hapten exposure predispose to atopic disease? The hapten-atopy hypothesis. Trends Immunol. 30 (2009) 67-74
52. Christen U., et al. Halothane metabolism: the dihydrolipoamide acetyltransferase subunit of the pyruvate dehydrogenase complex molecularly mimics trifluoroacetyl-protein adducts. Biochemistry 32 (1993) 1492-1499
53. Bruggraber S.F., et al. Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology 125 (2003) 1705-1713
54. Walden H.R., et al. Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway. Hepatology 48 (2008) 1874-1884
55. Leung P.S., et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J. Immunol. 170 (2003) 5326-5332
56. Amano K., et al. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J. Immunol. 172 (2004) 6444-6452
57. Leung P.S., et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J. Immunol. 179 (2007) 2651-2657
58. Wakabayashi K., et al. Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin. Exp. Immunol. 155 (2009) 577-586
59. Wakabayashi K., et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 48 (2008) 531-540
60. Rieger R., et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J. Autoimmun. 27 (2006) 7-16
61. Parikh-Patel A., et al. The association between gravidity and primary biliary cirrhosis. Ann. Epidemiol. 12 (2002) 264-272
62. Bogdanos D., et al. Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J. Hepatol. 49 (2008) 466-473
63. Invernizzi P., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363 (2004) 533-535
64. Selmi C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract. Res. Clin. Rheumatol. 22 (2008) 913-922
65. Sekigawa I., et al. DNA methylation: its contribution to systemic lupus erythematosus. Clin. Exp. Med. 6 (2006) 99-106
66. Patole P.S., et al. Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis. J. Autoimmun. 29 (2007) 52-59
67. Salas J.T., et al. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 134 (2008) 1482-1493
68. Palmer J.M., et al. Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology 39 (2004) 1583-1592
69. Ueno Y., et al. Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models. J. Gastroenterol. 42 (2007) 189-195
70. Padgett K.A., et al. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J. Autoimmun. 24 (2005) 209-219
71. Shi T., et al. Biodegradation of polycyclic aromatic hydrocarbons by Sphingomonas strains isolated from the terrestrial subsurface. J. Ind. Microbiol. Biotechnol. 26 (2001) 283-289
72. Selmi C., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38 (2003) 1250-1257
73. Olafsson S., et al. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am. J. Gastroenterol. 99 (2004) 2143-2146
74. Carrel L., and Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434 (2005) 400-404
75. Invernizzi P., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J. Immunol. 175 (2005) 575-578
76. Miozzo M., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 46 (2007) 456-462